RecruitingPsychological StressSleep DisturbanceAnxiety Symptoms

Sleep More, Stress Less: 90-Day Trial of Neuralli Mood

Eligible age

18+ yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This decentralized, single-arm study evaluates the effects of 90 days of daily Neuralli Mood supplementation on perceived stress, sleep disturbance, mood, anxiety, depressive symptoms, happiness, and occupational burnout in adults experiencing stress or occasional sleep disruption. Participants serve as their own controls, completing validated self-report measures before beginning supplementation and again after the 90-day intervention, with safety and adherence check-ins during the study.

Sponsor: Efforia, Inc

You may qualify if…

✓ Age 18 years or older and able to provide informed consent.
✓ Generally healthy adult experiencing stress, occasional sleep disruption, low mood, anxiety symptoms, or work-related burnout.
✓ Willing and able to take two capsules of Neuralli Mood daily for 90 days.
✓ Willing and able to complete electronic baseline, follow-up, adherence, and safety assessments.
✓ Has reliable access to the internet and an email-enabled device.

You may not qualify if…

✕ Pregnant or nursing.
✕ Known allergy or hypersensitivity to Neuralli Mood, probiotics, or any product ingredient.
✕ Severe or unstable gastrointestinal disease, including a condition for which probiotic use may be inappropriate.
✕ Immunocompromised status or current immunosuppressive therapy.
✕ Severe or unstable mood disorder, acute psychiatric symptoms, or a current risk of harm to self or others.
✕ A clinically significant sleep disorder for which participation or changes in symptoms should be managed by a healthcare professional.
✕ Cognitive impairment or another condition that prevents informed consent or reliable completion of study procedures.
✕ History of a severe allergic reaction when the investigator determines probiotic use may present an unacceptable risk.

Where it's recruiting

New York

Source: ClinicalTrials.gov · NCT07717385 · last updated 2026-07-21